Podcasts about next gen

What's the journey of an entrepreneur look like? And better yet, when it comes to diversifying your income... is day trading worth getting into?  Jose Echegoyen joins the podcast to share his startup story for Next-Gen Living, along with his favorite sides of day trading.  Learn more about Jose's business at https://www.nextgenliving.net/ Enjoy this episode? Check out supporting our podcast at Patreon.com/GoodAdvice. 

In this episode, Travis and Cody discuss not only becoming the goat everything that you do, but making it Next Gen in how you do it. Listen in, and enjoy!

Did 15 winners ever seem possible to KP? (1:00); “the most dangerous man in motorsports” (3:00); what it meant that Harvick “controlled” the race to snap a long winless streak (4:30); how KP saw the former high school wrestler from Bakersfield, California, seize the race (7:00); how experience might have hindered Rodney Childers' adaptation to the Next Gen car (9:30); Bubba's big heartbreak (12:00); is Bubba being too hard on himself? (13:30); how he will move on from it as a smarter, better driver (16:30); are Denny Hamlin and Michael Jordan rubbing off on Wallace, and is that a good thing? (19:00); the stakes for Ryan Blaney and Martin Truex Jr. (21:00); where things stand for Truex and the 19 team after a bumpy Michigan (26:00); KP's concerns on Blaney (28:00); what a year for Kyle Busch (30:00); the Ty Gibbs in Cup factor coupled with the Next Gen (32:30); and how Kyle Busch might perceive all of those factors (35:00); Denny Hamlin's disappointment and the continuing Gibbs errors (37:00); the eBay Motors MotorMouths of The Race: A memorable quote from Kevin Harvick (40:00); and what it reveals about what we always have known about Harvick (42:00); KP discusses his new book, “Swerve or Die” that was released this week (45:00); his reasons for writing it and how it became a very therapeutic process that helped him work through some unsettled (and dark) periods in life (46:30); 

If you are new and have never filled out a connect card, or you would love to recommit your life to Jesus Christ or commit for the first time please fill out this safe card. All your information is kept securely according to our privacy policy. https://oasischurchperth.churchcenter.com/people/forms/18669 For prayer requests please fill out https://oasischurchperth.churchcenter.com/people/forms/91959 or to speak to a pastor, please contact pastoralcare@oasischurchperth.com if you would like to know more about Oasis Church please see our website at www.oasischurchperth.com and follow us on our socials at https://www.facebook.com/oasischurchperthwa or https://www.instagram.com/oasischurchperth Our privacy policy can be found at https://www.oasischurchperth.com/oasis-church-privacy-policy/ --- Send in a voice message: https://anchor.fm/oasis-church-perth/message

Support World Evangelism by becoming a subscriber to the DAILY PREMIUM AD-FREE SERMON PODCAST using the links below: Subscribe to the premium podcast for only $3/month at Supercast: https://vbph-sermons.supercast.tech/ Subscribe to the premium version of this podcast in Apple Podcasts for $4.99/month: https://apple.co/3dix1mC ALL PROCEEDS GO TO WORLD EVANGELISM --- We need five-star reviews! Tell the world what you think about this podcast at: Apple Podcasts: https://apple.co/3dix1mC Podchaser: https://www.podchaser.com/podcasts/vbph-sermon-podcast-43369 Join our bible reading plan: https://bible.com/p/37105438/98d214149e0115fd6b7114ad30095ebf Want to receive text updates from our church? Send the keyword VBPH to 844-990-3380. Please let us know how this message has influenced you by connecting with us using one of these options: Email: pastor@vbph.org Voicemail: https://anchor.fm/vbph-sermons/message Facebook: https://facebook.com/vbph.church Instagram: https://instagram.com/vbph.church Twitter: https://twitter.com/vbph_church Website: https://vbph.church Are you in Hampton Roads and want to visit our church? Come join us IRL: 1045 Lynnhaven Pkwy., Virginia Beach, VA 23452 ---

In this episode, Dan chats with Brian Byrnes who is Head of Personal Finance at Moneybox. We chat about the cost of living crisis at the moment, how to make financial planning more accessible, and how Moneybox are introducing new ways to get people to think about their financial future. Join our community: https://bit.ly/3zwDVQA 

This week we interviewed Tim Wagner, CEO of Vendia. Vendia is a real-time data infrastructure provider that enables companies to securely share data across organizations, applications, and data lakes.  In this talk, we discussed the use of next-generation blockchain and server list infrastructure to solve data sharing problems related to security, privacy, and data management. We also explored the three body problem - how conventional IT, private ledgers, and public blockchains will work together to usher in the Web 3.0 era.  Key Questions:  What are the characteristics of a suitable use case for blockchain architecture?  How to distinguish between private and public ledgers?  How do data ownership and sharing mechanisms work for private blockchains?  What is the functionality and business logic of next generation blockchains?

With concussion symptoms improving Kurt Busch will still have to sit out Michigan with his substitute driver Ty Gibbs hearing all kinds of rumors about his future. Plus Kevin Harvick complains NASCAR too slow fix safety problems with Next Gen and Ryan Blaney believes we could get to 16 winners.

Shy of having a crystal ball to predict the future, venture capitalists have to rely on other skills to determine what companies to fund. With a decade of experience, Insight Partners Managing Director Thomas Krane knows how to spot innovative startups that are bringing a significant value-add to the market. Just as importantly, he's also looking for CEOs that understand the market value and how to make their product profitable. Learn more about the next generation of software VC!Tune in to learn:About How Insight Partners has grown in the last decade (08:43)Where the best innovation are in new startups for security, DevOps, or automation (15:09) How 10x is the standard improvement rate for NextGen Cybersecurity development (22:06)What factor is enabling the break-neck speed of tech innovation (28:22)About Thomas' career hop from the astronomy lab to venture capital (34:14)Where Thomas looks to find the next big thing to invest in (39:40)Mentions:“The Biggest Mistakes Companies Make With Cybersecurity—and How to Avoid Them” (article in The Wall Street Journal)Why Your Code is My Code with Sonatype's Derek Weeks (prior podcast episode of IT Visionaries)IT Visionaries is brought to you by Salesforce Platform. If you love the thought leadership on this podcast, Salesforce has even more meaty IT thoughts to chew on. Take your company to the next level with in-depth research and trends right in your inbox. Subscribe to a newsletter tailored to your role at Salesforce.com/newsletter.Mission.org is a media studio producing content for world-class clients. Learn more at mission.org.

There have been substantial developments on next gen vaccines. Luke O'Neill brings us all the details on the show this morning.

The new Babolat Pure Aero is here! In this episode, Olivier Carlier (Babolat Global Marketing Manager - Expert Racquets), joins us to talk all about the evolution of the iconic AERO line of Babolat racquets and how this new one came to be! What has changed, who should be using it and so much more!  In this episode:  - Pure Aero: an evolution of the AERO – from the APD to present day Pure Aero; what have been the key moments and most popular versions of the racquet? - What makes the AERO such an iconic racquet – can't just be Rafa?! Or can it?! - NextGen players using the Pure Aero: FAA, Carlos, Leylah, Danielle, Jen Brady, etc.  - How Babolat updates a franchise of racquets: from previous generation to new racquet: how they decide what to change & how they navigate between too much or too little change to make it enough of an “update” - What changes have been made with the new Pure Aero line: 100, 98, Lite and  Team - How important is the RA to the Pure Aero's playability and identity - Why the different string spacing for the heavy vs. light models - Who is the Pure Aero player? - Explain the flax fibers technology in the new Pure Aero - Best string set ups for the new Pure Aeros If you have any further questions or want to continue the conversation?! Email us at podcast@tennis-warehouse.com   Shop with us for all your TENNIS needs all over the WORLD:

This week on an all-new episode of "Authenticated," we debut an all-new segment to the show called, “Ask Lionel Racing.” If you've got questions that require more detail than can fit in 180 characters on Twitter, we can address them at length here on “Authenticated.” Just use #AskLionelRacing and we'll address more on future episodes. This time, we answer some questions about receiving paint schemes, race win processes, and some background details on our 1:64-scale die-cast. Plus, this week's show features a spirited discussion about the action at Indianapolis, some exciting new die-cast from drivers like Dale Earnhardt Jr. and more!

Go online to PeerView.com/JJJ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Are you ready to make personalized treatment choices with the potent suite of targeted agents, including BTK and BCL-2 inhibitors, that have become standards of care in chronic lymphocytic leukemia (CLL)? In collaboration with the CLL Society, this PeerView MasterClass & Case Forum, based on a live event at the ASCO Annual Meeting, will give learners foundational insights on the evidence that supports the use of personalized therapy with modern targeted platforms. Watch the expert panel present a series of highly practical case discussions that include guidance on: the evidence-based selection of treatment strategies for treatment-naïve and relapsed CLL; therapeutic planning based on safety considerations; and the integration of novel combinatorial and cellular therapy strategies. Don't miss this expert-led program and receive CME/MOC credit! Upon completion of this activity, participants should be better able to: Summarize updated efficacy and safety evidence supporting the integration of novel therapeutic classes in CLL, including evidence with BTK, PI3K, and BCL-2 inhibitors, novel combinations, and CAR-T options; Recommend personalized treatment with targeted agents, including fixed duration or continuous therapy strategies or appropriate combinatorial or sequential options, for patients presenting with treatment-naïve or relapsed/refractory CLL; and Manage unique safety considerations associated with the use of targeted agents, novel antibodies, or cellular therapies in the CLL setting.

Go online to PeerView.com/JJJ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Are you ready to make personalized treatment choices with the potent suite of targeted agents, including BTK and BCL-2 inhibitors, that have become standards of care in chronic lymphocytic leukemia (CLL)? In collaboration with the CLL Society, this PeerView MasterClass & Case Forum, based on a live event at the ASCO Annual Meeting, will give learners foundational insights on the evidence that supports the use of personalized therapy with modern targeted platforms. Watch the expert panel present a series of highly practical case discussions that include guidance on: the evidence-based selection of treatment strategies for treatment-naïve and relapsed CLL; therapeutic planning based on safety considerations; and the integration of novel combinatorial and cellular therapy strategies. Don't miss this expert-led program and receive CME/MOC credit! Upon completion of this activity, participants should be better able to: Summarize updated efficacy and safety evidence supporting the integration of novel therapeutic classes in CLL, including evidence with BTK, PI3K, and BCL-2 inhibitors, novel combinations, and CAR-T options; Recommend personalized treatment with targeted agents, including fixed duration or continuous therapy strategies or appropriate combinatorial or sequential options, for patients presenting with treatment-naïve or relapsed/refractory CLL; and Manage unique safety considerations associated with the use of targeted agents, novel antibodies, or cellular therapies in the CLL setting.

Go online to PeerView.com/JJJ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Are you ready to make personalized treatment choices with the potent suite of targeted agents, including BTK and BCL-2 inhibitors, that have become standards of care in chronic lymphocytic leukemia (CLL)? In collaboration with the CLL Society, this PeerView MasterClass & Case Forum, based on a live event at the ASCO Annual Meeting, will give learners foundational insights on the evidence that supports the use of personalized therapy with modern targeted platforms. Watch the expert panel present a series of highly practical case discussions that include guidance on: the evidence-based selection of treatment strategies for treatment-naïve and relapsed CLL; therapeutic planning based on safety considerations; and the integration of novel combinatorial and cellular therapy strategies. Don't miss this expert-led program and receive CME/MOC credit! Upon completion of this activity, participants should be better able to: Summarize updated efficacy and safety evidence supporting the integration of novel therapeutic classes in CLL, including evidence with BTK, PI3K, and BCL-2 inhibitors, novel combinations, and CAR-T options; Recommend personalized treatment with targeted agents, including fixed duration or continuous therapy strategies or appropriate combinatorial or sequential options, for patients presenting with treatment-naïve or relapsed/refractory CLL; and Manage unique safety considerations associated with the use of targeted agents, novel antibodies, or cellular therapies in the CLL setting.

Go online to PeerView.com/JJJ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Are you ready to make personalized treatment choices with the potent suite of targeted agents, including BTK and BCL-2 inhibitors, that have become standards of care in chronic lymphocytic leukemia (CLL)? In collaboration with the CLL Society, this PeerView MasterClass & Case Forum, based on a live event at the ASCO Annual Meeting, will give learners foundational insights on the evidence that supports the use of personalized therapy with modern targeted platforms. Watch the expert panel present a series of highly practical case discussions that include guidance on: the evidence-based selection of treatment strategies for treatment-naïve and relapsed CLL; therapeutic planning based on safety considerations; and the integration of novel combinatorial and cellular therapy strategies. Don't miss this expert-led program and receive CME/MOC credit! Upon completion of this activity, participants should be better able to: Summarize updated efficacy and safety evidence supporting the integration of novel therapeutic classes in CLL, including evidence with BTK, PI3K, and BCL-2 inhibitors, novel combinations, and CAR-T options; Recommend personalized treatment with targeted agents, including fixed duration or continuous therapy strategies or appropriate combinatorial or sequential options, for patients presenting with treatment-naïve or relapsed/refractory CLL; and Manage unique safety considerations associated with the use of targeted agents, novel antibodies, or cellular therapies in the CLL setting.

Go online to PeerView.com/JJJ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Are you ready to make personalized treatment choices with the potent suite of targeted agents, including BTK and BCL-2 inhibitors, that have become standards of care in chronic lymphocytic leukemia (CLL)? In collaboration with the CLL Society, this PeerView MasterClass & Case Forum, based on a live event at the ASCO Annual Meeting, will give learners foundational insights on the evidence that supports the use of personalized therapy with modern targeted platforms. Watch the expert panel present a series of highly practical case discussions that include guidance on: the evidence-based selection of treatment strategies for treatment-naïve and relapsed CLL; therapeutic planning based on safety considerations; and the integration of novel combinatorial and cellular therapy strategies. Don't miss this expert-led program and receive CME/MOC credit! Upon completion of this activity, participants should be better able to: Summarize updated efficacy and safety evidence supporting the integration of novel therapeutic classes in CLL, including evidence with BTK, PI3K, and BCL-2 inhibitors, novel combinations, and CAR-T options; Recommend personalized treatment with targeted agents, including fixed duration or continuous therapy strategies or appropriate combinatorial or sequential options, for patients presenting with treatment-naïve or relapsed/refractory CLL; and Manage unique safety considerations associated with the use of targeted agents, novel antibodies, or cellular therapies in the CLL setting.

Go online to PeerView.com/JJJ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Are you ready to make personalized treatment choices with the potent suite of targeted agents, including BTK and BCL-2 inhibitors, that have become standards of care in chronic lymphocytic leukemia (CLL)? In collaboration with the CLL Society, this PeerView MasterClass & Case Forum, based on a live event at the ASCO Annual Meeting, will give learners foundational insights on the evidence that supports the use of personalized therapy with modern targeted platforms. Watch the expert panel present a series of highly practical case discussions that include guidance on: the evidence-based selection of treatment strategies for treatment-naïve and relapsed CLL; therapeutic planning based on safety considerations; and the integration of novel combinatorial and cellular therapy strategies. Don't miss this expert-led program and receive CME/MOC credit! Upon completion of this activity, participants should be better able to: Summarize updated efficacy and safety evidence supporting the integration of novel therapeutic classes in CLL, including evidence with BTK, PI3K, and BCL-2 inhibitors, novel combinations, and CAR-T options; Recommend personalized treatment with targeted agents, including fixed duration or continuous therapy strategies or appropriate combinatorial or sequential options, for patients presenting with treatment-naïve or relapsed/refractory CLL; and Manage unique safety considerations associated with the use of targeted agents, novel antibodies, or cellular therapies in the CLL setting.

Here is another HGP throwback show#3 of HGP recorded back in 2014!! We will be back with #400 Soon, Promise...     Intro Music by Fantomenk - The Massacre(Rockband Version)  Outro Music by Fantomenk- Dis Chipo Join us in our group on Facebook -https://www.facebook.com/groups/HorribleGamers/ Like our Page -https://www.facebook.com/HorribleGamers/ Follow us on Twitter -https://twitter.com/_Horriblegamers Discord -https://discord.gg/8bsaxmD Patreon -https://www.patreon.com/horriblegamers If you like the show..Rate and Review It! Special Thanks to Our Patreon Supporters Jesus Loves You!   Check out Manscaped and keep your balls happy!  Get 20% OFF @manscaped + Free Shipping with promo code HGP20 at MANSCAPED.com! #ad #manscapedpod  

Go online to PeerView.com/JJJ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Are you ready to make personalized treatment choices with the potent suite of targeted agents, including BTK and BCL-2 inhibitors, that have become standards of care in chronic lymphocytic leukemia (CLL)? In collaboration with the CLL Society, this PeerView MasterClass & Case Forum, based on a live event at the ASCO Annual Meeting, will give learners foundational insights on the evidence that supports the use of personalized therapy with modern targeted platforms. Watch the expert panel present a series of highly practical case discussions that include guidance on: the evidence-based selection of treatment strategies for treatment-naïve and relapsed CLL; therapeutic planning based on safety considerations; and the integration of novel combinatorial and cellular therapy strategies. Don't miss this expert-led program and receive CME/MOC credit! Upon completion of this activity, participants should be better able to: Summarize updated efficacy and safety evidence supporting the integration of novel therapeutic classes in CLL, including evidence with BTK, PI3K, and BCL-2 inhibitors, novel combinations, and CAR-T options; Recommend personalized treatment with targeted agents, including fixed duration or continuous therapy strategies or appropriate combinatorial or sequential options, for patients presenting with treatment-naïve or relapsed/refractory CLL; and Manage unique safety considerations associated with the use of targeted agents, novel antibodies, or cellular therapies in the CLL setting.

Go online to PeerView.com/JJJ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Are you ready to make personalized treatment choices with the potent suite of targeted agents, including BTK and BCL-2 inhibitors, that have become standards of care in chronic lymphocytic leukemia (CLL)? In collaboration with the CLL Society, this PeerView MasterClass & Case Forum, based on a live event at the ASCO Annual Meeting, will give learners foundational insights on the evidence that supports the use of personalized therapy with modern targeted platforms. Watch the expert panel present a series of highly practical case discussions that include guidance on: the evidence-based selection of treatment strategies for treatment-naïve and relapsed CLL; therapeutic planning based on safety considerations; and the integration of novel combinatorial and cellular therapy strategies. Don't miss this expert-led program and receive CME/MOC credit! Upon completion of this activity, participants should be better able to: Summarize updated efficacy and safety evidence supporting the integration of novel therapeutic classes in CLL, including evidence with BTK, PI3K, and BCL-2 inhibitors, novel combinations, and CAR-T options; Recommend personalized treatment with targeted agents, including fixed duration or continuous therapy strategies or appropriate combinatorial or sequential options, for patients presenting with treatment-naïve or relapsed/refractory CLL; and Manage unique safety considerations associated with the use of targeted agents, novel antibodies, or cellular therapies in the CLL setting.

It's important to stay connected through the summer! Summer Life provides opportunities for our Next Gen kids and students to stay connected with each other and their leaders. We have events going on all summer! All grades are based off of fall 2022 school year. We hope to see you this summer for Summer Life!

Sponsored by Knapsack, the design system platform that brings teams together. Learn more at knapsack.cloud.Vojtech Miksu (Software Engineer at Uber) and Evan Lovely (Chief Architect at Knapsack) join Chris to discuss the gap between a frontend developer's code base and what actually gets shipped, the next-gen tool (Ladle) Vojtech created to address this, and ultimately helping developers get closer to what end users experience.View the transcript of this episode here.

On Scene First Ep. 38: A.K. Dozanti, Founder, Life Saver Wellness I am wicked excited to share this conversation with A.K. She is a First Responder Wellness Coach & Specialist that I connected with on Tik Tok. I am thrilled to share her with you all. Join us to hear about her mental health and wellness organization that is saving our first responders! Special thanks to our Premier Sponsor, NGA - Next Generation Advanced. For more information on all your NextGen 9-1-1 needs head on over to NGA 911 and tell them Tracy sent you.

Kids and students aren't just the future of the church, but the church right now. As we have for several years, we're taking one Sunday to highlight family ministries with Next Gen. Sunday. Next Gen. Sunday is a chance to challenge the larger church body to step up their role in setting the course for the next generation. It is also a chance to spotlight and celebrate all that's happened in Family Ministries in the past year.

Bentornati finalmente in un nuovo podcast OLDGEN. Argomento a caldo di oggi STRAY il giuoco dei GATTI

Kids and students aren't just the future of the church, but the church right now. As we have for several years, we're taking one Sunday to highlight family ministries with Next Gen. Sunday. Next Gen. Sunday is a chance to challenge the larger church body to step up their role in setting the course for the next generation. It is also a chance to spotlight and celebrate all that's happened in Family Ministries in the past year.

Message from Kento Mori on July 31, 2022

Dr Michael Lange host of "ask the dr" has been hosting live call-in talk show called "Ask The Dr" since April of 93 all over the world. Tune in each week while he discusses the latest in anti-aging, eye care and nutrition. Today's show discussed the importance of vitamins d and ways of getting it. Dr Lange announced the release of a brand-new multivitamin / eye vitamins called Fortifeye Next Gen Complete. He also discussed the importance of proper diet, proper supplements, exercise and weight management, sleep, hydration and adequate sunshine for your overall health and wellbeing. an in-depth discussion with a caller in regard to wet macular degeneration. Dr Lange said there is no cure or magic pill for macular degeneration, but treatments have come a long way! Dr Michael Lange recommended specific diet, specific foods, specific nutrients, blue filtering lenses, weight management to be used in conjunction with frequent visits to the retina doctor to help support the retinal health. Dr Richard Hall spoke about Fortifeye Fit and how it is great for anyone at any age for promoting muscle synthesis and strength. He also discussed how sarcopenia can be a nutritionally responsive disease as we age and practice some good dietary habits combined with exercise. Dr Hall discussed with a bodybuilder caller the importance of proper nutrition while training for bodybuilding events and powerlifting events. Many callers directed the topic of conversation today. Near the end Dr Lange responded to a social media question in regard to the latest Ocusoft Thermal 1 Touch procedure for opening the meibomian glands safely with no pain and minor expense. learn more and order at www.fortifeye.com call 866 503-9746 for more information on Fortifeye or to order.Support the show: https://www.drmichaellange.com/category/ask-the-doctor/See omnystudio.com/listener for privacy information.

   This week two films about master negotiators.      Small time con, Eddie, can sell anything to anyone. He dreams of one day opening his own store and sees it as his way out from under the ever more controlling grip of local crime boss, John Power. Unfortunately, right when it seems things might go Eddie's way for once, things take a turn toward the horrible as Power's nephew (and Eddie's partner) absconds with Power's young bride and a lockbox full of cash. Is there a light at the end of this tunnel or is there only death waiting Trojan Eddie?     The tenth film overall in the franchise. The fourth and final film with the Next Gen crew. The Enterprise-E is forced to deal with a coup within the Romulan Star Empire when a coup leaves Shinzon, an imperfect clone of the Enterprise's own captain Jean-Luc Picard, as Praetor. A box office disappointment, it led Paramount to declare "franchise fatigue" and put the franchise in a box on a low shelf for a few years. Fantastic ship effects and the always wonderful Patrick Stewart just weren't enough to save Star Trek: Nemesis.    Join us, won't you?Episode 268- Seamy Reman

Convinced your time of influence has come and gone? Doubt that anyone's still looking to you for wisdom or guidance? Think again. We change our world when we transform our homes. Each small act of obedience, every bold step of faith, furthers the Kingdom for generations to come.

Welcome back! After a month off from the podcast for our "summer vacation" (read: not vacation for Taylor since she's been planning their WEDDING), the three of us are back to discuss the cuts at this year's CrossFit Games, the latest Games documentary recently released & other nuggets from what an elite CrossFit competition is like from behind-the-scenes, plus some big news for Teddy. Enjoy listening.

Support World Evangelism by becoming a subscriber to the DAILY PREMIUM AD-FREE SERMON PODCAST using the links below: Subscribe to the premium podcast for only $3/month at Supercast: https://vbph-sermons.supercast.tech/ Subscribe to the premium version of this podcast in Apple Podcasts for $4.99/month: https://apple.co/3dix1mC ALL PROCEEDS GO TO WORLD EVANGELISM --- We need five-star reviews! Tell the world what you think about this podcast at: Apple Podcasts: https://apple.co/3dix1mC Podchaser: https://www.podchaser.com/podcasts/vbph-sermon-podcast-43369 Join our bible reading plan: https://bible.com/p/37105438/98d214149e0115fd6b7114ad30095ebf Want to receive text updates from our church? Send the keyword VBPH to 844-990-3380. Please let us know how this message has influenced you by connecting with us using one of these options: Email: pastor@vbph.org Voicemail: https://anchor.fm/vbph-sermons/message Facebook: https://facebook.com/vbph.church Instagram: https://instagram.com/vbph.church Twitter: https://twitter.com/vbph_church Website: https://vbph.church Are you in Hampton Roads and want to visit our church? Come join us IRL: 1045 Lynnhaven Pkwy., Virginia Beach, VA 23452 ---

This week's guest is Michael da Silva. Michael was born and raised in Toronto, Canada. After graduation, Michael worked for the Bank of Montreal in the Portuguese community in Toronto. After completing his MBA at Southern Methodist University in Dallas, TX, Michael now works in corporate finance for a major biotech company in the San Francisco Bay Area.

General thoughts on Kurt Busch missing Pocono with concussion-like symptoms and acknowledging racing's inherent dangers (1:30); the variables (and accompanying risks) that make racing different from other pro sports (3:30); why safety is a community issue (5:30); tracing the origins of the last safety revolution in NASCAR (7:15); reflecting on an era when conversations in NASCAR were contentious about safety (11:00); what's happening with drivers in Next Gen crashes (15:00); a focus on the headrest and foam (17:00); staying proactive while acknowledging that “driving a race car is not a safe endeavor” (18:00); what's the next step for the SAFER barrier? (20:00); “Things happen at speed” – understanding the risks drivers accept and the indescribable feeling of what it's like to hit walls at 190 mph (22:00).

The latest episode of The Dynamite Effect is now live for your listening pleasure! Your host and humble guide Keila Cash recaps the highs and lows from AEW Dynamite. The Rundown Includes: Jon Moxley vs. Rush for the Interim AEW World Championship delivers the goods, Ricky Starks cuts a career-defining babyface promo before getting stabbed in the back by Powerhouse Hobbs, Dante Martin and Sammy Guevara have hops for days, Jungle Boy cuts the promo of his life, Thunder Rosa vs. Miyu Yamashita for the AEW Women's World Championship lives up to the hype, and Bryan Danielson vs. Daniel Garcia ends the night on a surprising note. Press play and FOLLOW me today!Follow me on Instagram: https://instagram.com/wrestlesoaptopiaFollow me on Twitter: https://twitter.com/ladywrestlingx

John Wu, CEO of Gryphon, joins the pod with Scott Kitun. Gryphon is a wireless router built around online safety, privacy and protecting the central point of your digital life at home. John first starting thinking about the idea for the router after watching his young daughter access the internet and come across NSFW (or children) content. Scott and John catch up about the essential role of data in our lives, why we should care where it goes and treating children's digital lives with equivalent protections and safeguards we use in the physical world. John also shares new features coming to Gryphon including password manager functionalities, VPN and other privacy protections using  blockchain technology that transfer control away from third parties and into the hands of the user.  Gryphon is currently raising a CF round on Republic. 

In this episode, our host Tate Chamberlin is joined by Olympian, facilitator, and community organizer Pamphinette Buisa with HATCH NextGen activists and students Olivia Bulis and Ruby Jenni in reflections on diversity, decolonization, systems change, and why empowering youth may be the first step toward a brighter future for all.

What is the faith of the next generation worth? What is the faith of the next generation worth to you? Scripture: Joshua 4

Some California farmers are switching to self-driving electric tractors. Learn more about your ad choices. Visit megaphone.fm/adchoices

Co-hosts Klaudia Tirico and Kelly Lindenau play back a noteworthy tape from #B2BMX: Next-Level ABM starring Rob Griffin and Thad Kahlow! The pair from Business Online discuss the three pillars that are essential for driving advanced ABM: Expertise, empathy and bold action. They explained how marketers tend to get lost in the complexities of ABM and data, so alignment is key to developing an overall successful program. Griffin and Kahlow teach marketers how to navigate through the endless amounts of data, intent signals and technologies so they can understand key areas of prioritization. Tune into this episode to learn more about advancing your ABM by asking: Is my ABM program helping accelerate pipeline?  Is my ABM program helping close revenue from an account perspective? If the answer is no to these two questions… it's time to re-evaluate your ABM program!RELATED LINKS Register For B2BSMX In Boston Say Goodbye To MQLs, No Thanks To MQAs & Hello To Opportunities

If you've listened to or watched a NASCAR race in the past 50 years, there's a voice that is synonymous with some of the sport's biggest moments. Legendary broadcaster Mike Joy joins Dale Earnhardt Jr. and co-host Mike Davis to fill listeners in on his career, as well as talk shop about the broadcasting craft. After a meteoric rise from the PA booth of New England's finest short tracks, Joy has gone on to work for almost every major broadcasting network in motorsports over the past five decades.  Growing up in Windsor, Connecticut, Joy enrolled at the University of Hartford pursuing a degree in engineering. It was here that he got his first on-air experience after taking a position at the university's radio station as a play-by-play commentator for sporting events. It was also during these years that he became involved in the world of motorsports. He had developed a love for sports cars as a teenager, thanks to an extensive collection of auto magazines and his father's acquisition of a two-seater that the two worked on. His admiration for the road racing experts of the day, such as Dan Gurney and Mark Donohue sparked an interest to join the driving ranks himself. But without proper funding or opportunity, he settled into the sport of autocross where competitors could use their street vehicles.  His autocross club brought him to Riverside Park Speedway in Agawam, Massachusetts – a small pavement oval located in an amusement park. Thanks to his broadcasting experience, he was asked to hop on the microphone during an autocross meet one Sunday to help inform any park attendees who may have wandered into the track exactly what was happening in the competition. Before long, park owner Ed Carroll noticed that a few hundred people had gathered in the grandstands to watch a single car weaving around barrels, and invited Joy on board to become a fill-in PA announcer. Although he initially turned down the offer, citing a disinterest in the crude jalopies of the oval racing circuit, he attended a Saturday night show at the recommendation of the track's public relations specialist. After witnessing a mad dash to the finish between two drivers and the effect it had on the audience, Joy thought “I need to be a part of this.” Joy fills Dale and Mike in on how taking the position at Riverside introduced him to the legendary Ken Squier, and how that guided him to joining the Motor Racing Network. He talks about an opportunity he received to call some of the 1975 IROC race at Daytona, and how that moment made him realize that he could have a career in broadcasting.  The conversation also dives into the art of commentating, and how different platforms require different approaches. Joy recounts a hilarious story of sneaking into the 1976 Daytona 500 and joining in on the Wood Brothers' victory lane celebration. He also shares the details of his final conversation with Dale Earnhardt Sr. Although known for his contributions to the sport from inside the broadcaster's booth, Joy still managed to have a career in road racing, and shares the details of his 1973 IMSA debut, as well as his experiences in the 1993 24 Hours of Daytona. In 2022, Joy celebrated his 22nd consecutive year as lead commentator for the Daytona 500. It also marked his 46th year of involvement with Daytona Speedweeks, a record that may never be eclipsed.  DIRTY AIR presented by Filtertime Before Mike Joy joins the show, Dale, Mike and Matthew get real about: NASCAR's wild weekend at Pocono Denny Hamlin's pass for the lead considered retaliation against Ross Chastain? Ty Gibbs subbing in for Kurt Busch The future of Kyle Busch   ASKJR presented by Xfinity Alex Timms brings fan questions to Dale about: The advantage the NextGen rear view camera provides The upcoming modified opening races at North Wilkesboro Hanging with Noah Gragson in victory lane Collecting diecast cars To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

David Armstrong and Jessica Gibbs of Monument Wealth Management describe how their firm helps employees advance and why it embraces “opinionated” content.

In this episode, my twin sister and I talk real estate and education. Are you in the real estate business? Thinking about a career in real estate? If so, technology can make a break a real estate agent. The next generation uses technology as soon as they can hold it in their hands. Therefore, agents must embrace technology today! Need help with going live? Go to https://smartgirlmedia.kartra.com/page/journal Start creating content today! Carrie's eblast nationally bit.ly/learnwithcarrie The agent journey membership bit.ly/agentjourney https://www.youtube.com/c/CarrieJLittle www.instagram.com/carriejolittle - live on Friday's --- Send in a voice message: https://anchor.fm/carriejolittle/message Support this podcast: https://anchor.fm/carriejolittle/support

Our guest today is Austin Smith. Austin is a proud 5th-Generation Arizonan and Conservative Republican who is campaigning for election to be an AZ State Representative in LD 29. 1) What drove you to put your hat in the ring? And what key issues are you eager to positively impact? 2) What would you say to other people who are hesitant to dive into the rough and tumble world of politics? 3) Through your work with Turning Point Action you have helped to develop leadership among thousands of young people. And we have titled this episode, “Next Gen Leadership”. Based on your experience, what would you say about the outlook of the future? 4) How did you choose your running mates, Steve Montenegro & Janae Shamp? 5) What uniquely qualifies you to be fill one of the seats in the Arizona State House as a Representative for LD29?

Setting up the Denny Hamlin-Kyle Busch disqualifications (1:00); DJ's thoughts after the details came to light (3:30); providing some context on the new DQ era of the 21st century (6:30); should NASCAR be inspecting more cars with greater scrutiny after races? (8:00); NASCAR's new message to the garage (12:00); the penalty of perception with a disqualification (15:00); the strain and stress of a turbulent season on Joe Gibbs (17:30); Latest round of Denny Hamlin vs. Ross Chastain (21:00): why DJ says Hamlin's move was aggressively fair (23:30); a Tyler Reddick-Chase Elliott battle with meaning in retrospect (25:00); Chase Elliott the title favorite (26:00); DJ reflects on current concussion protocol vs. when he raced through them (27:00); DJ's concerns with the Next Gen car and heavy impacts (29:30); career-best finish for Jimmie Johnson at Iowa Speedway (32:30); and a quick preview of the IndyCar-NASCAR doubleheader weekend at Indianapolis Motor Speedway (35:00)

“We need to move away from animal derived materials, but we also need to move away from petroleum based traditional materials. So what is out there, what can we do? That demand is strong and supply is where the issue is.”  - Sydney Galdman     On June 12th the New York Times put out an article titled, How Fashion Giants Recast Plastic as Good for the Planet. The article, written by Hiroko Takeuchi, caused quite a stir within the Species Unite and I'm sure many other vegan communities. It criticizes something called the Higg Index, a suite of tools that assesses social and environmental impacts of products, including animal based and synthetic materials. The article left many people confused and I received a lot of emails asking me, “should we even be wearing vegan leather?” (The answer is yes.)   In order to be better able to explain what the article was really about, I needed some help. So, I reached out to my friend Nicole Rawling, the executive director at the Material Innovation Initiative (MII), the non-profit that's advancing next gen materials. Next gen materials are high performance, animal free and more sustainable for fashion, automotive and home goods. MII provides expertise while bringing all the key players together to get these materials from concept to commercialization.   Nicole introduced me to Sidney Gladman, the chief scientific officer at MII and Ranjani Theregowda, MII's environmental data scientist, so that they could answer my many questions about the article, about the future of materials as well as our current situation. I have been excited about next gen materials for a long time, but I'm even more so after speaking with them. It's happening - we're on the way and to a future that no longer uses animals for fashion, autos, and home goods. And, MII is doing everything that they can to speed that future up.   LINKS: https://www.materialinnovation.org/   Instagram https://www.instagram.com/materialinnovation/   Facebook https://www.facebook.com/MaterialInnovation/

Welcome to another episode of the NASCAR Gambling Podcast on the Sports Gambling Podcast Network! Every Rod Villagomez and Cody Zeeb bring their love of NASCAR and their love of sports betting to you to help you set your bets for the weekend of NASCAR action. From the Camping World Truck Series to the Xfinity Series, to the Cup Series, Rod and Cody have you covered. This week, we preview the M&M's Fan Appreciation 400, as well as the Truck Series race and Xfinity Series races at Pocono Raceway and give you some of our favorite bets. How will the Next Gen car handle the "Tricky Triangle?" Can Kyle Busch shed his demons and claim another victory in the Poconos? Will Cody ever quit betting Chase Elliott? We'll answer these questions and more on this week's episode. Be sure to subscribe to the NASCAR Gambling Podcast on the SGPN App, and on Apple Podcasts or Spotify. Find Rod (@rjvillagomez) and Cody (@Husker_Zeeb) on Twitter. SGPN Merch Store - https://sg.pn/store Download The Free SGPN App - https://sgpn.app WynnBET - Bet $50 Get $200 In Free Bets - https://sg.pn/WynnBET Join Sleeper and get a 100% deposit bonus up to $100 - http://sleeper.com/sgp Support for this episode - IPVanish.com/sgp Follow The Sports Gambling Podcast On Social Media Twitter - http://www.twitter.com/NascarGambling   Follow The Hosts On Social Media Rod Villagomez - http://www.twitter.com/rjvillagomez Cody Zeeb - http://www.twitter.com/Husker_Zeeb   Watch the Sports Gambling Podcast YouTube - https://www.sg.pn/YouTube Twitch - https://www.sg.pn/Twitch   Read & Discuss - Join the conversation Website - https://www.sportsgamblingpodcast.com Discord - https://sg.pn/discord Reddit - https://www.sg.pn/reddit Learn more about your ad choices. Visit podcastchoices.com/adchoices

A weekend in New England left Brett Griffin, Freddie Kraft and TJ Majors with lots of stories to tell. After two eventful races at New Hampshire Motor Speedway and a busy week of silly season news, the crew reacts to everything that went down. First, find out how Brett learned some Boston slang and why payment was required to spot the modifieds. Then the guys dive into Spot On, Spot Off. First, they discuss Martin Truex Jr.'s decision to take two tires during the last pit stop which cost him the win and placed the No. 19 team on the playoff cutoff line. Now given Christopher Bell as the 14th different winner this season, they talk about how many drivers they expect to see win before the playoffs begin. Brad Keselowski and Austin Dillon swerved at each other and made contact under caution on Sunday. T.J. talks about what led Keselowski to retaliate against Dillon and what each of them said in their post-race interviews. Tyler Reddick announced he signed with 23XI Racing for the 2024 season last week. The spotters applaud Reddick for his move but share their displeasure about Richard Childress Racing's actions. While the timing of the announcement seemed strange, find out why 23XI needed to share the news first. Afterwards, they talk about who could race in the No. 8 car next. Ty Dillon will not return to Petty-GMS Racing after this season and the crew doesn't find this surprising. Hear about who is the leading candidate to drive the 42 car next year and why they would be the most interesting Cup driver in the field. Next, NASCAR did not penalize Christopher Bell's team for losing a wheel coming off pit road last week at Atlanta. The guys express their frustration towards NASCAR making a judgment call and why the penalty needs to have stricter guidelines for what is and isn't a penalty. Finally, producer Jason Schultz reads Joey Logano's comments on Next Gen crashes. The spotters talk about NASCAR's confusion between what the drivers say about hits and what their data shows compared to the previous car. In Reaction Theatre, find out why Jesse Iwuji may now see the light, the guys learn about Austin Dillon's TV show, and Jeb is back with a song. #AskDBC returns in the Offerpad question of the week segment and in What an Idiot, learn about the embarrassing incident at Bowman Gray. Thank you to our presenting sponsor Offerpad and partners Xfinity and RacingUSA.com for making this show possible.      Learn more about your ad choices. Visit podcastchoices.com/adchoices